Atlas Trials

Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)

Clinical trial NCT02832128 · COMPLETED

Trial details

NCT number
NCT02832128
Sponsor
Autifony Therapeutics Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hearing LossHearing Impairment
Start date
2016-05-01
Primary completion
2017-04-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.